Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Status: Enrolling
Updated:  12/28/2017
VA Pittsburgh Health System
mi
from
Pittsburgh, PA
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Status: Enrolling
Updated: 12/28/2017
VA Pittsburgh Health System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Status: Enrolling
Updated:  12/28/2017
MedStar Heart & Vascular Institute
mi
from
Washington,
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Status: Enrolling
Updated: 12/28/2017
MedStar Heart & Vascular Institute
mi
from
Washington,
Click here to add this to my saved trials
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Status: Enrolling
Updated:  12/28/2017
Washington DC VA Medical Center
mi
from
Washington,
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Status: Enrolling
Updated: 12/28/2017
Washington DC VA Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Genetic Predictors of Outcome in HCM Patients
Genetic Predictors of Outcome in HCM Patients
Status: Enrolling
Updated:  1/2/2018
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Genetic Predictors of Outcome in HCM Patients
Genetic Predictors of Outcome in HCM Patients
Status: Enrolling
Updated: 1/2/2018
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Exercise and Cognitive Retraining to Improve Cognition in Heart Failure.
The Feasibility of Exercise and Cognitive Retraining to Improve Memory, Attention and Concentration in Heart Failure.
Status: Enrolling
Updated:  1/2/2018
Emory University Heart Failure Clinics
mi
from
Atlanta, GA
Exercise and Cognitive Retraining to Improve Cognition in Heart Failure.
The Feasibility of Exercise and Cognitive Retraining to Improve Memory, Attention and Concentration in Heart Failure.
Status: Enrolling
Updated: 1/2/2018
Emory University Heart Failure Clinics
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Washington Hospital Center, Medstar Research Institute
mi
from
Washington,
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Washington Hospital Center, Medstar Research Institute
mi
from
Washington,
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Jim Moran Heart and Vascular Research Institute
mi
from
Fort Lauderdale, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Jim Moran Heart and Vascular Research Institute
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Shands Jacksonville Medical Center (UFL)
mi
from
Jacksonville, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Shands Jacksonville Medical Center (UFL)
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Cardiology Research Associates
mi
from
Ormond Beach, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Cardiology Research Associates
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Emory University Hospital
mi
from
Atlanta, GA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Advocate Good Shephard Hospital
mi
from
Barrington, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Advocate Good Shephard Hospital
mi
from
Barrington, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Rush University Medical Center
mi
from
Chicago, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Chicago
mi
from
Chicago, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Trinity Medical Center
mi
from
Rock Island, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Trinity Medical Center
mi
from
Rock Island, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Midwest Cardiovascular Research Foundation
mi
from
Davenport, IA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Midwest Cardiovascular Research Foundation
mi
from
Davenport, IA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Kentucky, Gill Heart Institute
mi
from
Lexington, KY
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Kentucky, Gill Heart Institute
mi
from
Lexington, KY
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Henry Ford Hospital, Heart & Vascular Institute
mi
from
Detroit, MI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Henry Ford Hospital, Heart & Vascular Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Genesys Regional Medical Center
mi
from
Grand Blanc, MI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Genesys Regional Medical Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Saint Mary's Duluth Clinic Health Center
mi
from
Duluth, MN
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Saint Mary's Duluth Clinic Health Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Saint-Luke's Hospital / Mid America Heart Institute
mi
from
Kansas City, MO
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Saint-Luke's Hospital / Mid America Heart Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
UNC Health Systems
mi
from
Chapel Hill, NC
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
UNC Health Systems
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Genesis Health Care System
mi
from
Zanesville, OH
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Genesis Health Care System
mi
from
Zanesville, OH
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Black Hills Clinical Research Center
mi
from
Rapid City, SD
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Black Hills Clinical Research Center
mi
from
Rapid City, SD
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Northwest Texas Healthcare System_Amarillo Heart Clinical Research Institute, Inc.
mi
from
Amarillo, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Northwest Texas Healthcare System_Amarillo Heart Clinical Research Institute, Inc.
mi
from
Amarillo, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Austin Heart, P.A.
mi
from
Austin, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Austin Heart, P.A.
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Methodist Hospital
mi
from
Houston, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Providence Health Center
mi
from
Waco, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Providence Health Center
mi
from
Waco, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
UVA Cardiology, UVA Health System
mi
from
Charlottesville, VA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
UVA Cardiology, UVA Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Mcguire Va Medical Center
mi
from
Richmond, VA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Comprehensive Cardiology Care
mi
from
Milwaukee, WI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Comprehensive Cardiology Care
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Alberta Hospital, WMC
mi
from
Edmonton,
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Alberta Hospital, WMC
mi
from
Edmonton,
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Suncoast Cardiovascular Research
mi
from
Saint Petersburg, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Suncoast Cardiovascular Research
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Saint Louis University Hospital
mi
from
Saint Louis, MO
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Saint Louis University Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Allegheny Hospital
mi
from
Pittsburgh, PA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Allegheny Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Muscle Afferent Feedback Effects in Patients With Heart Failure
Muscle Afferent Feedback Effects in Patients With Heart Failure: The Development of Central Fatigue
Status: Enrolling
Updated:  1/4/2018
George E Wahlen Vetern Affairs Medical Center
mi
from
Salt Lake City, UT
Muscle Afferent Feedback Effects in Patients With Heart Failure
Muscle Afferent Feedback Effects in Patients With Heart Failure: The Development of Central Fatigue
Status: Enrolling
Updated: 1/4/2018
George E Wahlen Vetern Affairs Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Muscle Afferent Feedback Effects in Patients With Heart Failure
Muscle Afferent Feedback Effects in Patients With Heart Failure: The Development of Central Fatigue
Status: Enrolling
Updated:  1/4/2018
Veterans Affairs Salt Lake City Heath Care System
mi
from
Salt Lake City, UT
Muscle Afferent Feedback Effects in Patients With Heart Failure
Muscle Afferent Feedback Effects in Patients With Heart Failure: The Development of Central Fatigue
Status: Enrolling
Updated: 1/4/2018
Veterans Affairs Salt Lake City Heath Care System
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated:  1/4/2018
University of California, San Diego
mi
from
San Diego, CA
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated: 1/4/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated:  1/4/2018
Thomas Jefferson University
mi
from
Philadelphia, PA
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated: 1/4/2018
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated:  1/4/2018
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated: 1/4/2018
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated:  1/4/2018
Heart and Diabetes Center - West Rhine-Westphalia
mi
from
Bad Oeynhausen,
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
Status: Enrolling
Updated: 1/4/2018
Heart and Diabetes Center - West Rhine-Westphalia
mi
from
Bad Oeynhausen,
Click here to add this to my saved trials
Link-HF, Phase II: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation
Link-HF, Phase II: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation
Status: Enrolling
Updated:  1/5/2018
Palo Alto VA Health Care System
mi
from
Palo Alto, CA
Link-HF, Phase II: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation
Link-HF, Phase II: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation
Status: Enrolling
Updated: 1/5/2018
Palo Alto VA Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials